Quit Genius
Quit Genius is pioneering digital therapeutics for multiple addictions.
Quit Genius has raised €64M across 2 funding rounds from 5 investors, most recently a Series B round in Jul 2021. Based in London, UK; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€64M
€64,466,293
Funding rounds
2
Investors
5
distinct backers
Active since
2020-03
latest 2021-07
Funding by year
EUR raised per yearQuit Genius — funding by year — interactive chart.
Data table
| Quit Genius — funding by year | |
|---|---|
| 2020 | €10M |
| 2021 | €54M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-21 | Series B | €54M | Atomico,Kinnevik,Octopus Ventures,Startup Health,Triple Point Ventures | View deal → |
| 2020-03-18 | Series A | €10M | Octopus Ventures | View deal → |